Lazada Urged to Remove Unregistered E-Cigarettes in Philippines

Mar.16.2023
Lazada Urged to Remove Unregistered E-Cigarettes in Philippines
Lazada urged to remove unregistered e-cigarettes from its platform, similar to Shopee, in compliance with Philippine e-cigarette regulations.

The Philippine E-Cigarette Industry Association (PECIA) and the Philippine Nicotine Consumers Union (NCUP) are urging Lazada to follow in the footsteps of Shopee and remove unregistered e-cigarette products in compliance with the country's Vaporized Nicotine and Non-Nicotine Products Regulation Act (RA 11900), which will take effect on July 25, 2022.


The bill covers electronic cigarette products, e-cigarette juices, e-cigarette devices, heated tobacco products, HTP consumables and devices, and new tobacco products. With the IRR set to take effect on December 28, 2022, all prohibited items under RA 11900 will no longer be sold in online and offline retail markets.


Joey Dulay, the president of PECIA, has stated that Lazada, being one of the most popular online markets, should ensure consumer welfare and protect them from unregistered and substandard products that may cause harm.


The Ministry of Industry has stated unequivocally that Lazada is responsible for complying with e-cigarette-related legislation. Shopee is a platform similar in size to Lazada, and has taken down more than one million unregistered e-cigarette listings from its website. Lazada should also take this issue seriously.


In January of this year, NCUP wrote separate letters to Shopee and Lazada, commending Shopee for taking swift and decisive action against illegal electronic cigarette products, and strongly encouraging Lazada to follow the example set by its competitor.


These platforms have a huge influence on consumers. If they see it on websites, they will think it is safe. Lazada plays a crucial role in preventing the consumption of illegal products. There are now appropriate laws to regulate electronic cigarettes, but if the platform itself does not comply, the law cannot be enforced," said NCUP President Anton Israel in the letter.


On March 1st, representatives from electronic commerce platforms met with the Department of Trade and Industry (DTI) through the Consumer Protection Group (CPG) to address the issue of banned nicotine and non-nicotine vaping products being advertised and sold online despite ongoing monitoring and law enforcement efforts.


On March 1, 2022, the Department of Trade and Industry (DTI) of the Philippines held a meeting with representatives from e-commerce platforms through the Consumer Protection Group (CPG) to address the issue of prohibiting the sale of illegal e-cigarettes online.


One day after the dialogue, Shopee reported that it had removed over one million illegal listings of electronic cigarettes from its platform. It also pledged to strengthen its monitoring of illegal electronic cigarette products and commit to continued cooperation with the trade organization.


Under RA 11900, only electronic cigarette products, devices, and new tobacco products that are registered and certified by the Philippines' Bureau of Standards (BPS) and accompanied by appropriate health warnings can be sold to the public by June 2024.


PECIA is the largest trade organization for electronic cigarettes in the Philippines, with over 200 member shop owners, suppliers, and manufacturers, as well as more than 8,000 E-cigarette alliances, representing over one million smokeless product consumers in the Philippines.


NCUP is a non-profit national advocacy organization that believes the rights and interests of millions of smokers and electronic cigarette users in the Philippines need to be protected from the influence of untested, unregulated, and unregistered products.


Reference:


Lazada has been requested to take down illegal vaping products from its online marketplace.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | Four CrossBar 20K 13mL High-Puff Vapes Listed on Pennsylvania's ENDS Directory, Rated for Up to 20,000 Puffs
Product | Four CrossBar 20K 13mL High-Puff Vapes Listed on Pennsylvania's ENDS Directory, Rated for Up to 20,000 Puffs
Four CrossBar 20K disposable e-cigarettes appeared on Pennsylvania's 163-entry ENDS directory ahead of enforcement beginning October 19, 2026. The devices feature 13mL e-liquid reservoirs, 50mg/mL nicotine, 2,000mAh batteries and 0.9Ω mesh coils, with advertised puff counts of up to 20,000. CrossBar was the only modern high-puff disposable series among the directory's 15 disposable entries. Its packaging emphasizes New York design and Japanese-origin flavoring, while historical CrossBar records identify a registered U.S. tobacco manufacturing-related establishment. The link between the newer 13mL devices and earlier 1.3mL PMTA filings remains unconfirmed.
product
Oct.26
Indiana Halts Sales of Elf Bar, Lost Mary, MR FOG and iJOY Vapes Under Foreign-Adversary Rules; Some Products Return After Compliance Filings
Indiana Halts Sales of Elf Bar, Lost Mary, MR FOG and iJOY Vapes Under Foreign-Adversary Rules; Some Products Return After Compliance Filings
Indiana's Alcohol and Tobacco Commission (ATC) ordered tobacco certificate holders in September to remove certain vaping products marketed under Elf Bar, Lost Mary, MR FOG, iJOY and other brands from inventory under the state's foreign-adversary product law. The agency later listed 257 MR FOG products and 77 Lost Mary product entries as lawful for sale. The Lost Mary revision expressly stated that compliance evidence had been received for 20 additional products. 2Firsts compliance expert Kurt said potential filings could include e-liquid and ingredient-origin records, U.S. nicotine-analog supply-chain documentation and FDA premarket application status.
Regulations
Oct.08
Huabao International Buys Indonesian HNB Manufacturer for RMB 90 Million, Adding OEM/ODM Capacity
Huabao International Buys Indonesian HNB Manufacturer for RMB 90 Million, Adding OEM/ODM Capacity
Huabao International Holdings Limited will acquire 100% of PT Broad Far Indonesia through two wholly owned subsidiaries for approximately RMB 90 million. The Indonesian company manufactures and sells heat-not-burn tobacco sticks and provides OEM/ODM services. The sellers are part of a related-party group controlled by Huabao International Chair and controlling shareholder Zhu Linyao. PT Broad Far Indonesia generated $4.37 million in revenue and $177,000 in profit after tax in the first half of 2026, while net assets stood at about $326,000 at June-end. An independent valuer assessed the company’s equity at approximately RMB 93.06 million. Following completion, the HNB manufacturing operation will be consolidated into Huabao International.
News
Sep.29 by 2Firsts Perspectives
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
PMI Launches Fourth IQOS Convenience-Store Discount of 2026 for Black Friday in Japan, Cutting ILUMA i ONE to About $19 After Ploom AURA Fell to About $9
PMI Launches Fourth IQOS Convenience-Store Discount of 2026 for Black Friday in Japan, Cutting ILUMA i ONE to About $19 After Ploom AURA Fell to About $9
Philip Morris Japan launched its fourth confirmed nationwide convenience-store discount campaign for IQOS ILUMA i devices in 2026 on October 26, cutting three models by as much as ¥2,000, or about $12.70. The campaign began one day after JT ended a promotion that reduced Ploom AURA to ¥1,480, or about $9.40. JT says Ploom's share of Japan's heated-products category rose from 10.9% in January 2024 to 18.3% in June 2026, a gain of 7.4 percentage points, while PMI says IQOS still held about 68% category share in the third quarter. At the same time, Japan's two-stage heated-tobacco tax adjustment has pushed stick prices higher, leaving device discounts as an increasingly important tool for lowering the upfront cost of customer acquisition.
Market
Oct.28
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23